Pharmafile Logo
Pharmafocus logo
Advanced Search

Liver Diseases

Showing 1 posts of 1 posts found.

EVerZom enters research and licensing agreement with GENFIT

November 13, 2025
Research and Development EVerZom, Eviv, GENFIT, Liver Diseases, collaboration, licensing agreement

EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025